An observational study in Parkinson Disease and Dysphagia, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. Status unknown. Per ClinicalTrials.gov, last updated 2021-06-16.
Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University · Observational
We recruited 116 patients with idiopathic PD who were from the Neurology clinic of the Second Affiliated Hospital of Zhejiang University, School of Medicine from January 2014 to November 2014. Perform videofluroscopic swallowing study and psychiatric and neurological evaluations and followed up after 6 years.
In baseline, 116 patients with idiopathic PD were recruited from the Neurology Clinic of the Second Affiliated Hospital of Zhejiang University School of Medicine according to the United Kingdom PD Society Brain Bank Clinical Diagnostic Criteria. They were admitted from January 2014 to November 2014, and were followed up after 6 years.
Perform psychiatric and neurological evaluations. And use Videofluoroscopic swallowing study (VFSS) to assess the swallowing function of PD patients. Added 200mg of barium sulfate to 286ml water to achieve a concentration of 60%. Add a thickener (Ourdiet Swallow, Ourdiet Biotech Co. Ltd, Guangzhou, China) to prepare juice and pudding viscosities, No thickener was added to the liquid viscosity. The patients were advised to have boluses of 3, 5 and 10 ml of the liquid, juice, pudding viscosities in sequence according to the clinician's instructions under X-ray fluoroscopy. The patients ware sitting or standing, The lateral view of the patients' swallow was recorded by a camera (30 frames per second). The radiologist, the clinician, and the rehabilitation therapist completed this examination. Two person analyzed the video in slow motion and frame - by - frame, and record abnormal results. The VFSS inspection parameters are Penetration/aspiration score and Residue score. In order to reduce the influence of drugs on dysphagia, all patients were in the off - period. The patients stopped taking anti-Parkinson's disease drugs from 9 o'clock the night before the examination, and were tested in the morning (free of medicine for more than 12 hours).
The patients had completed the above tests in 2014 and were asked to perform the above assessments again.
710 studies on the registry are indexed under Deglutition Disorders; 219 are open to participants now.
This study's enrollment of 116 is above the median of 97 across 207 observational studies indexed under Deglutition Disorders.
Browse Deglutition Disorders studies →Second Affiliated Hospital, School of Medicine, Zhejiang University is the lead sponsor of 1,058 studies on the registry; 511 are open to participants now.
Counted across the registry records on this site, refreshed daily.
116 idiopathic PD
Exclusion Criteria:
performing deep brain stimulation if needed
Also known as: DBS
Using anti-parkinsonian drugs if needed
Also known as: Anti-Parkinsonian medicine
penetration - aspiration score
according to the 8-Point Penetration-Aspiration Scale, PAS ≥ 6 means that material enters below the vocal cords.
Time frame: in the morning, before taking anti-parkinson drugs
residue score
evaluate the residue in the oral cavity and pharynx (vallecula, pyriform sinuses) after the first swallowing. Residue amount was rated on a scale from 0 to 3: no residue visible, 0 score; mild residue (less than 25% of the level of the height of the structure), 1 score; moderate residue (25% to 50% of the height of the structure), 2 score; severe residue (high than 50% of the structure height), 3 score.
Time frame: in the morning, before taking anti-parkinson drugs
water swallow test
The patient is asked to sit in a chair, and is handed a cup containing 30 mL of water at normal temperature. The patient is then asked to "Please drink this water as you usually do." Time to empty a cup is measured, and the drinking profile and episodes are monitored and assessed.
Time frame: in the morning, before taking anti-parkinson drugs
SDQ-C
The Chinese version of the Swallowing Disturbance Questionnaire
Time frame: in the morning, before taking anti-parkinson drugs
MMSE
Mini-mental State Examination (MMSE)；
Time frame: in the morning, before taking anti-parkinson drugs
HAMD
Hamilton Depression Scale
Time frame: in the morning, before taking anti-parkinson drugs
HAMA
Hamilton Anxiety Scale
Time frame: in the morning, before taking anti-parkinson drugs
H&Y
Hoehn-Yahr stage
Time frame: in the morning, before taking anti-parkinson drugs
PDQ-39
Parkinson Disease Quality of Life Measure
Time frame: in the morning, before taking anti-parkinson drugs
NMSQ
Non-Motor Symptoms Quest
Time frame: in the morning, before taking anti-parkinson drugs
No study locations are listed for this record.
Plan to share: No
This study is status unknown, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Second Affiliated Hospital, School of Medicine, Zhejiang University